Story

Intuit Tumbles on Weak Guidance; Semtech Surges After Strong Earnings Report

ENTHMSVIIDZHZH-TWJAKOHI
Aug 26, 20262 min read
Intuit Tumbles on Weak Guidance; Semtech Surges After Strong Earnings Report
Text size
Background

Shares of Intuit Inc. plummeted in premarket trading Wednesday after the financial software firm issued a disappointing forward-looking forecast, while semiconductor manufacturer Semtech Corp. surged on the back of record quarterly results and a robust outlook.

Earnings and Guidance Drive Major Moves

Intuit (INTU) stock fell sharply by 11.8% after the company's fiscal 2027 guidance came in significantly below analyst expectations, according to Investing.com. The weak outlook overshadowed a fourth-quarter earnings report that beat estimates, underscoring investor focus on future growth prospects over past performance.

In contrast, Semtech (SMTC) shares jumped 4.7% after reporting record fiscal second-quarter results. The chipmaker posted revenue of $341.9 million and adjusted earnings per share of $0.71, beating consensus estimates. The company's data-center revenue was a standout, growing 91% year-over-year, and its third-quarter forecast for revenue and earnings also significantly surpassed Wall Street's projections.

Also reacting to earnings, nCino (NCNO), a cloud banking software provider, saw its shares decline 4.9%. The drop followed a fiscal second-quarter report where its adjusted earnings per share of $0.05 missed analyst expectations of approximately $0.27 by a wide margin.

Analyst Actions and Corporate News

Sample IUX Markets – In-articleAd

Analyst ratings and corporate developments also drove significant premarket activity.

  • SolarEdge Technologies (SEDG): Shares rose 5.6% after UBS upgraded the stock to 'Buy' from 'Neutral' and increased its price target to $42. The bank cited a new U.S. Federal Communications Commission rule restricting certain foreign-made power inverters, which could improve SolarEdge's competitive position.
  • GoDaddy (GDDY): Shares slipped 3.5% following a downgrade from Wells Fargo to 'Underweight' from 'Equal Weight,' with a new price target of $76. The report noted this was the first sell-equivalent rating from analysts covering the web-services firm.
  • Boston Scientific (BSX): The medical device maker's stock traded down 3.2% after it disclosed a cybersecurity incident that disrupted its IT systems and affected its ability to process and fulfill customer orders.

Other Notable Movers

Spyre Therapeutics (SYRE) saw its stock fall 11.7% despite reporting statistically significant Phase 2 trial results for its rheumatoid arthritis treatment. The company announced it would not advance the drug as a standalone therapy because the efficacy fell short of its internal benchmarks, disappointing investors.

Shares of Sadot Group (SDOT) climbed 10.3% after the company filed to register a secondary offering of up to 4.25 million shares by existing stockholders, as the stock continues to see speculative interest.

Read next

More on Stocks
Back to latest news

LATEST